Live tape
Top 8, mentions 7d10,595TSLA2,251 mentions▲ +0.05GOOGL1,489 mentions▲ +0.04CRWV1,422 mentions▲ +0.03SPCX1,338 mentions▲ +0.07NVDA1,184 mentions▲ +0.07QQQ1,154 mentions▲ +0.05NBIS915 mentions▲ +0.06META842 mentions▲ +0.05

Equity · Healthcare

ORMP

NASDAQ

Oramed Pharmaceuticals (ORMP)

$4 0.00% vs prior close Finazon · prior-day close, indicative (IEX-derived, not the official close) · Oct 19, 2026

Reddit mentioned ORMP 1 times in the 30 days to 20 October 2026, in 1 of the communities we track. All of them were scored for sentiment: 0% read bullish, 0% bearish and 100% neither. Reddit data updated 20 October 2026.

Price · Chart
41 sessions
$5.5 $3.5 6 Aug 19 Oct

The line runs $4.30 on 6 August through $4 on 19 October, on a scale from $3.5 to $5.5. Days the market did not trade hold the previous close, flat.

Market cap $166.4M
P/E (TTM) 1.0
52-week range $2.21 – $5.35
Avg volume 10.3K
Mentions · 30d 1

as of Oct 19, 2026

Oramed Pharmaceuticals (ORMP) · crowd attention × price

Share ↗
1 mentions

Day4 Oct 2026

MENTIONS10–2 / day
PRICE$4.48 · closedMARKET CLOSED · held
ORMP over the last 30 days, plotting daily Reddit mentions as bars, left-hand scale; the daily closing price as a line on its own right-hand scale, solid across consecutive trading days, held flat and diagonally hatched over days the market was closed, diagonally hatched over days we hold no close for.per day012usd$3.5$4.0$4.5$5.021 Sep28 Sep6 Oct13 Oct20 Oct
ORMP over the last 30 days, plotting daily Reddit mentions as bars, left-hand scale; the daily closing price as a line on its own right-hand scale, solid across consecutive trading days, held flat and diagonally hatched over days the market was closed, diagonally hatched over days we hold no close for.21 Sep6 Oct20 Oct

Before our first record — not zero

The Distributed Sentinel 20 Oct 2026

ORMP drew 1 Reddit mentions over the 30 days to 20 October 2026

This chart in words

The chart plots daily Reddit mentions of ORMP over the 30 days to 20 October 2026: 1 in total, busiest on 4 October with 1, and 1 on the last day counted. The line is the daily close over the same window: $4.76 on 28 September, $4 on 19 October. Of those days, 16 were trading sessions and the other 14 are hatched on the chart. On 6 of them no session took place, and the last close before it is carried forward rather than plotted; on 2 of them no session took place, and this window holds no earlier close to carry forward; on 6 of them we hold no close at all, which is a gap in our own record rather than a closure we can prove.

Oramed Pharmaceuticals (ORMP) on Reddit · 30d

n = 1 scored · Method

In the 30 days to 21 Oct 2026, Oramed Pharmaceuticals drew 1 Reddit mention in the finance subreddits we track, 1 of them scored for sentiment.

1 mention of ORMP was scored for sentiment in these 30 days, so that one reading IS the sample. A bullish or bearish share of it could only ever read 0% or 100%, which states the sample size and not the crowd — so none is drawn. The chart on this page applies the same 5-mention floor to every day it plots.

Where ORMP is discussed

(30d)
r/wallstreetbets 100% 1 +0.04

Oramed Pharmaceuticals (ORMP) insider trades

SEC Form 4 · last 90 days · newest reported trade 1 Oct 2026

In the 90 days to 21 Oct 2026, Oramed Pharmaceuticals insiders reported 2 open-market sales and no purchases (SEC Form 4); the filings we hold, back to 31 Dec 2025, show no open-market purchase.

Open-market buys 0
Open-market sells 2
Net sold $226K
Non-trade filings 4
Date Insider Type Shares Value
01 Oct 2026 Gabay Avraham Chief Financial Officer Sell 20,000 $90K
01 Oct 2026 Hexter Joshua COO & CBO Sell 30,000 $135K

Compensation mechanics Share grants, option exercises, tax withholding and transfers. They reach the same Form 4 as a trade, but they are not the insider buying or selling on the open market, so no purchase or sale value applies to them.

Date Insider Type Shares Value
24 Sep 2026 KIDRON NADAV President and CEO Award 718,262
24 Sep 2026 Hexter Joshua COO & CBO Award 284,746
24 Sep 2026 Kidron Miriam Chief Scientific Officer Award 417,416
24 Sep 2026 Gabay Avraham Chief Financial Officer Award 209,291

Oramed Pharmaceuticals (ORMP) reported financials

SEC EDGAR XBRL SEC EDGAR

Oramed Pharmaceuticals reported revenue of $2.0M for the fiscal year ended 31 Dec 2025. Net income over the same period was $64.1M.

Figure Reported Period
Revenue $2.0M 31 Dec 2025 fiscal year
Net income $64.1M 31 Dec 2025 fiscal year
Diluted EPS $1.50 31 Dec 2025 fiscal year
Total assets $369.6M 30 Jun 2026 at period end
Total equity incl. minority interest $317.5M 30 Jun 2026 at period end

Oramed Pharmaceuticals (ORMP) earnings

SEC EDGAR

Oramed Pharmaceuticals last reported earnings on 30 Jun 2026 for Q2 2026, with EPS of $1.84; no next date is announced in SEC filings yet.

Date Period EPS Revenue
30 Jun 2026 Q2 2026 $1.84 —
31 Mar 2026 Q1 2026 $0.91 —
31 Dec 2025 FY 2025 $1.50 $2M
30 Sep 2025 Q3 2025 $1.13 $2M
30 Jun 2025 Q2 2025 $0.31 $2M
31 Mar 2025 Q1 2025 −$0.19 $2M
31 Dec 2024 FY 2024 −$0.48 —
30 Sep 2024 Q3 2024 −$0.48 —

Next report no date announced in SEC filings yet

Reported figures & scheduled dates · SEC EDGAR filings

Oramed Pharmaceuticals (ORMP) institutional holders (13F)

SEC Form 13F SEC EDGAR

4 of the 45 institutional funds we track reported a Oramed Pharmaceuticals position for the quarter ended 30 Jun 2026 — a combined $1.7M; the latest of those filings landed 02 Sep 2026.

Fund Action Shares Value
Renaissance Technologies Held (±25%) +24.4% shares 183,800 $884K
Marshall Wace Trimmed −60.7% shares 101,953 $490K
Citadel Advisors Trimmed −57.9% shares 41,565 $200K
Millennium Management Added +36.5% shares 21,861 $105K

Oramed Pharmaceuticals (ORMP) fails-to-deliver

SEC CNS data SEC

On 25 Sep 2026, 2 shares of Oramed Pharmaceuticals failed to deliver (about $10) — the latest of 2 consecutive trading days with recorded fails.

Settlement date Shares failed Notional % of shares out
25 Sep 2026 2 $10 <0.001%
24 Sep 2026 1,306 $6K 0.003%
21 Sep 2026 685 $3K 0.002%
17 Sep 2026 33 $152 <0.001%
16 Sep 2026 15 $69 <0.001%

Congressional trades in Oramed Pharmaceuticals (ORMP)

STOCK Act disclosures House disclosures

The most recent congressional trade disclosed in Oramed Pharmaceuticals is a purchase by Andrew R. Garbarino (house, NY), dated 23 Apr 2021.

Date Member Type Amount
23 Apr 2021 filed 24 May 2021 Andrew R. Garbarino house · Republican–NY Purchase $1K–$15K

Oramed Pharmaceuticals (ORMP): frequently asked questions

From live data

Have Oramed Pharmaceuticals insiders bought or sold shares recently?

In the 90 days to 21 Oct 2026, Oramed Pharmaceuticals insiders reported 2 open-market sales and no purchases (SEC Form 4); the filings we hold, back to 31 Dec 2025, show no open-market purchase. A further 4 filings were grants, awards, gifts or exercises rather than open-market trades.

How many institutions hold Oramed Pharmaceuticals?

4 of the 45 institutional funds we track reported a Oramed Pharmaceuticals position for the quarter ended 30 Jun 2026, per SEC Form 13F filings.

Has Oramed Pharmaceuticals had fails-to-deliver recently?

Yes. The most recent SEC fails-to-deliver record for Oramed Pharmaceuticals is dated 25 Sep 2026, when 2 shares failed to deliver.

When did Oramed Pharmaceuticals last report earnings?

Oramed Pharmaceuticals last reported earnings on 30 Jun 2026 for Q2 2026, with EPS of $1.84; no next date is announced in SEC filings yet.

What exchange is Oramed Pharmaceuticals listed on?

Oramed Pharmaceuticals trades on NASDAQ under the ticker ORMP.

Who is the CEO of Oramed Pharmaceuticals?

Nadav Kidron leads Oramed Pharmaceuticals (ORMP) as chief executive.

What is Reddit saying about Oramed Pharmaceuticals?

Oramed Pharmaceuticals was mentioned 0 times in the last 7 days across the finance subreddits we track, and 1 times over the trailing 30 days. Of 1 classified mentions, 0% read bullish, 0% bearish and 100% neutral. Crowd sentiment is a social signal, not investment advice.

Answers are generated from the live figures on this page — Reddit crowd data, SEC filings and open company records — and update as the data does.

Sources

  1. Finazonprior-day close, indicative (IEX-derived, not the official close), some closes dollar-rounded at the source
  2. TradingViewthe price chart widget, drawn by TradingView from their own data
  3. RedditReddit ingest across the tracked finance subreddits
  4. SEC EDGARSEC EDGAR XBRL company facts · latest period ended 30 Jun 2026
  5. SEC EDGARSEC EDGAR 13F filings
  6. SECSEC fails-to-deliver (CNS) data
  7. House disclosuresU.S. House of Representatives financial disclosures
  8. SEC EDGARValuation computed from SEC EDGAR filings